UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades

Clinical and experimental rheumatology, 2012-07, Vol.30 (4), p.561

2012

Volltextzugriff (PDF)

Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

Annals of the rheumatic diseases, 2004-12, Vol.63 (12), p.1664-1669

2004

Volltextzugriff (PDF)

NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis

The Lancet (British edition), 2000-11, Vol.356 (9243), p.1739-1740

2000

Volltextzugriff (PDF)

Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis

Seminars in arthritis and rheumatism, 2003-04, Vol.32 (5), p.285-295

2003

Volltextzugriff (PDF)

Vitamin E gel reduces time of healing of digital ulcers in systemic sclerosis

Clinical and experimental rheumatology, 2009-05, Vol.27 (3 Suppl 54), p.51

2009

Volltextzugriff (PDF)

Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis

Rheumatology (Oxford, England), 2007-05, Vol.46 (5), p.772-775

2007

Volltextzugriff (PDF)

Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases

Experimental and clinical endocrinology & diabetes, 2004-10, Vol.112 (9), p.542-544

2004

Volltextzugriff (PDF)

Circulating levels of Nε -(carboxymethyl )lysine are increased in systemic sclerosis

Rheumatology (Oxford, England), 2007-03, Vol.46 (3), p.412-416

2007

Volltextzugriff (PDF)

Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement

Annals of the rheumatic diseases, 2002-08, Vol.61 (8), p.682-686

2002

Volltextzugriff (PDF)

Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement

Annals of the rheumatic diseases, 2005-03, Vol.64 (3), p.382-387

2005

Volltextzugriff (PDF)

Therapy of spondylarthropathy in inflammatory bowel disease

Clinical and experimental rheumatology, 2002-11, Vol.20 (6 Suppl 28), p.S88

2002

Volltextzugriff (PDF)

Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis

Rheumatology (Oxford, England), 2005-05, Vol.44 (5), p.607-613

2005

Volltextzugriff (PDF)

Raynaud's phenomenon and vascular disease in systemic sclerosis

Advances in experimental medicine and biology, 1999, Vol.455, p.93

1999

Volltextzugriff (PDF)

Peripheral nervous system in limited systemic sclerosis

Reumatismo, 2011-09, Vol.56 (4), p.247-252

2011

Volltextzugriff (PDF)

Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment

Clinical and experimental rheumatology, 1998-09, Vol.16 (5), p.527

1998

Volltextzugriff (PDF)

Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma)

Annals of the rheumatic diseases, 2001-05, Vol.60 (5), p.487-494

2001

Volltextzugriff (PDF)

Circulating levels of N -(carboxymethyl)lysine are increased in systemic sclerosis

Rheumatology (Oxford, England), 2007-03, Vol.46 (3), p.412-416

2007

Volltextzugriff (PDF)

Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis

Journal of rheumatology, 2001-01, Vol.28 (1), p.198

2001

Volltextzugriff (PDF)

Prostaglandin E1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosis

Clinical and experimental rheumatology, 2001-05, Vol.19 (3), p.358

2001

Volltextzugriff (PDF)

Systemic sclerosis. A clinical overview

Advances in experimental medicine and biology, 1999, Vol.455, p.73

1999

Volltextzugriff (PDF)

Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface

Life sciences (1973), 1998, Vol.63 (6), p.441-453

1998

Volltextzugriff (PDF)

The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms

Rheumatic diseases clinics of North America, 1996-11, Vol.22 (4), p.879

1996

Volltextzugriff (PDF)

Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement

Rheumatology (Oxford, England), 2009-08, Vol.48 (8), p.920-925

2009

Volltextzugriff (PDF)

Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis

Annals of the rheumatic diseases, 1996-10, Vol.55 (10), p.745-748

1996

Volltextzugriff (PDF)

Bcl-2, p53 and c-myc expression in juvenile dermatomyositis

Clinical and experimental rheumatology, 2000-09, Vol.18 (5), p.643

2000

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(71)
Science & Technology
(55)
Life Sciences & Biomedicine
(52)
Male
(49)
Female
(48)
Biological And Medical Sciences
(38)
Medical Sciences
(37)
Middle Aged
(36)
Rheumatology
(33)
Adult
(24)
Systemic Sclerosis
(23)
Aged
(20)
Scleroderma, Systemic - Physiopathology
(16)
Diseases Of The Osteoarticular System
(11)
Scleroderma, Systemic - Complications
(11)
Scleroderma, Systemic - Pathology
(10)
Peptidyl-Dipeptidase A - Blood
(8)
Pharmacology. Drug Treatments
(7)
Scleroderma, Systemic - Drug Therapy
(7)
Child
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades

Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis

Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis

Vitamin E gel reduces time of healing of digital ulcers in systemic sclerosis

Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis

Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases

Circulating levels of Nε -(carboxymethyl )lysine are increased in systemic sclerosis

Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement

Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement

Therapy of spondylarthropathy in inflammatory bowel disease

Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis

Raynaud's phenomenon and vascular disease in systemic sclerosis

Peripheral nervous system in limited systemic sclerosis

Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment

Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma)

Circulating levels of N -(carboxymethyl)lysine are increased in systemic sclerosis

Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis

Prostaglandin E1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosis

Systemic sclerosis. A clinical overview

Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface

The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms

Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement

Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis

Bcl-2, p53 and c-myc expression in juvenile dermatomyositis

Suchergebnisse filtern